Trever G. Bivona

机构：City College of San Francisco, University of California, San Francisco, Chan Zuckerberg Initiative (United States), UCSF Helen Diller Family Comprehensive Cancer Center, University of San Francisco · ORCID：0000-0001-5734-4128

发表论文 361 篇 · 总被引 22455 次 · h-index 68

代表论文

• Acquired resistance in cancer: towards targeted therapeutic strategies (2025 · Nature reviews. Cancer · 被引 108)
• Myeloid-mesenchymal crosstalk drives ARG1-dependent profibrotic metabolism via ornithine in lung fibrosis (2025 · Journal of Clinical Investigation · 被引 21)
• Temporal photoproximity labeling of ligand-activated EGFR neighborhoods using MultiMap (2025 · Nature Chemical Biology · 被引 12)
• Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer (2025 · Journal of Thoracic Oncology · 被引 9)
• Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies (2026 · Nature Communications · 被引 3)
• In vivo manipulation of the protein homeostasis network in rhabdomyosarcoma (2025 · Oncotarget · 被引 3)